ArticleBMC geriatrics2025
Short-term and long-term reversion rates to normal cognition and their contributing factors among individuals with mild cognitive impairment in a Japanese community: the Hisayama study.
Article in BMC geriatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Article
- Cognitive trajectories and mortality risk in older adults: a 9-year follow-up study.GeroScience · 2026Article
- Development of a New Tablet-Based Cognitive Screening Test for Community-Dwelling Older Adults.Cureus · 2026Article
- Evaluate the Risk Factors of Mild Cognitive Impairment (MCI) in Patients with Type 2 Diabetes Mellitus (T2DM): A Cross-Sectional Study.Diabetes, metabolic syndrome and obesity : targets and therapy · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundIndividuals with mild cognitive impairment (MCI) have a high risk of developing dementia, but some remain cognitively stable or even revert to normal cognition (NC), with reported reversion rates varying widely and inconsistent findings regarding contributing factors. The purposes of this study were to investigate the reversion rate from MCI to NC in a community-dwelling older Japanese population and to identify factors associated with reversion.
methodsThree community-based surveys of cognitive function were conducted in the town of Hisayama among residents aged 65 years or older in 2012-2013, 2017-2018, and 2022-2023 (participation rate > 92% for each time range). The 5-year reversion rate from MCI to NC was examined using a pooled cohort, combining two cohorts from the 2012-2013 to the 2017-2018 survey and from the 2017-2018 to the 2022-2023 survey. A logistic regression analysis with generalized estimating equations was used to identify factors associated with reversion to NC based on the pooled cohort data. To evaluate the 10-year reversion rate of MCI, moreover, 171 participants diagnosed with MCI in the 2012-2013 survey were followed for 10 years.
resultsThe 5-year reversion rate from MCI to NC in the pooled cohort was 31.3% (95% confidence interval, 26.9%-36.2%). Younger age, lower systolic blood pressure, absence of diabetes mellitus, absence of instrumental activities of daily living impairment, higher handgrip strength, higher Mini-Mental State Examination (MMSE) score, larger total brain volume, and smaller cerebral white matter lesion volume were significantly associated with reversion to NC. Meanwhile, the 10-year reversion rate from MCI to NC was 18.1% (13.1%-24.6%). Of individuals who reverted from MCI to NC in the 2017-2018 survey, 48.1% (35.0%-61.5%) maintained NC five years later, 32.7% (21.4%-46.4%) returned to MCI, and 5.8% (1.9%-16.4%) progressed to dementia.
conclusionsIn a Japanese community-dwelling older population with MCI, approximately 30% and 18% reverted to NC for 5 years and 10 years, respectively. The prevention and proper management of lifestyle-related diseases and promotion of healthy lifestyle behaviors may play a crucial role in facilitating reversion to NC in older individuals with MCI.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.